Proteins that are significantly modulated after ATRA treatment at 24, 72, and 96 hours through AACT analysis
. | . | . | . | . | Peptides sequenced . | Protein expression† . | . | . | . | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Accession no. . | Protein name . | Functional classification . | Mr, kDa* . | pl* . | . | 24 h . | 72 h . | 96 h . | mRNA expression‡ . | ||
P04720 | eEF1A-1 | Protein synthesis | 50.1 | 9.10 | 5 | 0.67 | 0.32 | 0.36 | Unchanged∥24 | ||
P29692 | EF-1-δ | Protein synthesis | 31.1 | 4.90 | 2 | 0.80 | 0.53 | ND | Unchanged24 | ||
AAH09865 | eEF1γ | Protein synthesis | 50.1 | 6.25 | 4 | 0.35 | 0.41 | 0.38 | Unchanged∥ | ||
P46199 | IF-2 | Protein synthesis | 81.3 | 6.71 | 2 | ND | 0.47 | 0.35 | Unchanged24 | ||
P04765 | eIF4A-1 | Protein synthesis | 46.1 | 5.32 | 3 | 0.53 | 0.34§ | 0.40§ | Unchanged∥ | ||
P55010 | eIF5 | Protein synthesis | 49.2 | 5.41 | 2 | ND | 0.48 | ND | Unchanged24 | ||
P42655 | 14-3-3ϵ | Signal transduction | 29.1 | 4.63 | 4 | 0.66 | 0.44 | 0.41§ | Unknown | ||
P29312 | 14-3-3ζ/δ | Signal transduction | 27.7 | 4.73 | 2 | 0.81 | 0.58 | 0.59 | Unknown | ||
P01112 | c-H-ras | Signal transduction | 21.2 | 5.16 | 2 | ND | ND | 0.19 | Unknown | ||
P00540 | c-mos | Signal transduction | 37.8 | 9.15 | 3 | ND | 0.43 | 0.38 | Unknown | ||
P30153 | PP2A | Signal transduction | 65.0 | 4.96 | 2 | 0.70 | 0.35 | 0.41 | Unknown | ||
Q13233 | MEKK 1 | Signal transduction | 164 | 8.52 | 3 | 0.92 | ND | 0.64 | Repressed24 | ||
P23528 | Cofilin, P18 | Structural | 18.5 | 8.22 | 9 | 0.51 | 0.64 | 0.52 | Repressed24 | ||
P32119 | Peroxiredoxin 2 | Cellular defense | 21.9 | 5.66 | 5 | ND | 0.47 | 0.50 | Unknown | ||
C28894 | MPO | Cellular defense | 92.4 | 9.25 | 9 | 0.35 | 0.52 | 0.48 | Repressed23 | ||
P25763 | CDC42 homolog | Not defined | 21.3 | 6.16 | 3 | 0.35 | 0.54 | ND | Repressed24 | ||
P10809 | 60-kDa hsp | Chaperone | 61.0 | 5.70 | 7 | 0.77 | 0.67 | 0.48 | Repressed23 | ||
Q9NR31 | SAR1a | Transport | 22.4 | 6.22 | 4 | ND | 0.18 | 0.20 | Unknown | ||
P12270 | Nucleoprotein TPR | mRNA transport | 266 | 5.01 | 6 | 0.88 | 0.50 | 0.48 | Unknown | ||
P07910 | hnRNP C1/C2 | mRNA splicing | 33.7 | 4.95 | 3 | 0.64 | 0.55 | ND | Unchanged∥ | ||
Q07244 | hnRNP K | mRNA transport | 50.9 | 5.39 | 6 | 0.52 | 0.53 | 0.50 | Unchanged∥ | ||
P07029 | hnRNP UP2 | mRNA splicing | 24.1 | 8.02 | 1 | 1.0 | 0.68 | ND | Unchanged∥ | ||
P43331 | snRNP D3 | mRNA splicing | 13.9 | 10.3 | 2 | ND | 0.39 | 0.41 | Unchanged∥25 | ||
P08578 | snRNP E | mRNA splicing | 10.8 | 9.46 | 2 | 0.71 | 0.62 | 0.59 | Unchanged∥ | ||
Q13822 | E-NPP 2 | Glycolysis | 99.0 | 7.14 | 2 | ND | ND | 0.31 | Unknown | ||
P22712 | MBP-1 | Transcription | 37.0 | 6.79 | 2 | ND | 0.15 | ND | Unknown | ||
Q9BWX5 | GATA-5 | Transcription | 41.3 | 9.17 | 1 | 1.5 | ND | 2.6 | Unknown | ||
Q14974 | Importin β-1 | Transport | 97.2 | 4.68 | 2 | 1.5 | ND | 2.1 | Repressed24 | ||
P24903 | CYPIIF1 | Cellular defense | 55.5 | 6.93 | 2 | 1.6 | ND | 1.8 | Unknown | ||
P52565 | Rho GDI 1 | Signal transduction | 23.2 | 5.03 | 2 | 2.3 | 1.7 | ND | Unknown | ||
P31146 | Coronin 1A | Signal transduction | 51.0 | 6.25 | 3 | 2.2 | ND | ND | Unknown | ||
NP_000994 | 60S P1 protein | Protein synthesis | 11.5 | 4.26 | 2 | 1.0 | 1.5 | 1.8 | Unknown | ||
P15531 | NDP kinase A | Energy | 17.1 | 5.83 | 2 | 0.9 | 1.5 | ND | Unknown | ||
P05109 | Calgranulin A | Cellular defense | 10.8 | 6.51 | 2 | ND | 2.0 | 2.1 | Induced23 | ||
Q99733 | NAP2 | Not defined | 42.7 | 4.60 | 3 | 1.2 | ND | 1.9 | Unknown | ||
P47755 | CapZ α-2 | Structural | 32.9 | 5.57 | 2 | 1.8 | 2.2 | 2.6 | Unknown | ||
P12814 | α-actinin 1 | Structural | 103 | 5.22 | 3 | 2.7 | 2.3 | 2.8 | Unknown | ||
Q08043 | α-actinin 3 | Structural | 103 | 5.40 | 3 | 3.4 | ND | ND | Unknown | ||
P35579 | NMMHC-A | Structural | 226 | 5.50 | 3 | 2.0 | 4.1 | 4.3 | Unknown | ||
P29590 | isoform PML-1 | Negative regulator | 97.5 | 5.88 | 2 | 3.5 | ND | ND | Unknown |
. | . | . | . | . | Peptides sequenced . | Protein expression† . | . | . | . | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Accession no. . | Protein name . | Functional classification . | Mr, kDa* . | pl* . | . | 24 h . | 72 h . | 96 h . | mRNA expression‡ . | ||
P04720 | eEF1A-1 | Protein synthesis | 50.1 | 9.10 | 5 | 0.67 | 0.32 | 0.36 | Unchanged∥24 | ||
P29692 | EF-1-δ | Protein synthesis | 31.1 | 4.90 | 2 | 0.80 | 0.53 | ND | Unchanged24 | ||
AAH09865 | eEF1γ | Protein synthesis | 50.1 | 6.25 | 4 | 0.35 | 0.41 | 0.38 | Unchanged∥ | ||
P46199 | IF-2 | Protein synthesis | 81.3 | 6.71 | 2 | ND | 0.47 | 0.35 | Unchanged24 | ||
P04765 | eIF4A-1 | Protein synthesis | 46.1 | 5.32 | 3 | 0.53 | 0.34§ | 0.40§ | Unchanged∥ | ||
P55010 | eIF5 | Protein synthesis | 49.2 | 5.41 | 2 | ND | 0.48 | ND | Unchanged24 | ||
P42655 | 14-3-3ϵ | Signal transduction | 29.1 | 4.63 | 4 | 0.66 | 0.44 | 0.41§ | Unknown | ||
P29312 | 14-3-3ζ/δ | Signal transduction | 27.7 | 4.73 | 2 | 0.81 | 0.58 | 0.59 | Unknown | ||
P01112 | c-H-ras | Signal transduction | 21.2 | 5.16 | 2 | ND | ND | 0.19 | Unknown | ||
P00540 | c-mos | Signal transduction | 37.8 | 9.15 | 3 | ND | 0.43 | 0.38 | Unknown | ||
P30153 | PP2A | Signal transduction | 65.0 | 4.96 | 2 | 0.70 | 0.35 | 0.41 | Unknown | ||
Q13233 | MEKK 1 | Signal transduction | 164 | 8.52 | 3 | 0.92 | ND | 0.64 | Repressed24 | ||
P23528 | Cofilin, P18 | Structural | 18.5 | 8.22 | 9 | 0.51 | 0.64 | 0.52 | Repressed24 | ||
P32119 | Peroxiredoxin 2 | Cellular defense | 21.9 | 5.66 | 5 | ND | 0.47 | 0.50 | Unknown | ||
C28894 | MPO | Cellular defense | 92.4 | 9.25 | 9 | 0.35 | 0.52 | 0.48 | Repressed23 | ||
P25763 | CDC42 homolog | Not defined | 21.3 | 6.16 | 3 | 0.35 | 0.54 | ND | Repressed24 | ||
P10809 | 60-kDa hsp | Chaperone | 61.0 | 5.70 | 7 | 0.77 | 0.67 | 0.48 | Repressed23 | ||
Q9NR31 | SAR1a | Transport | 22.4 | 6.22 | 4 | ND | 0.18 | 0.20 | Unknown | ||
P12270 | Nucleoprotein TPR | mRNA transport | 266 | 5.01 | 6 | 0.88 | 0.50 | 0.48 | Unknown | ||
P07910 | hnRNP C1/C2 | mRNA splicing | 33.7 | 4.95 | 3 | 0.64 | 0.55 | ND | Unchanged∥ | ||
Q07244 | hnRNP K | mRNA transport | 50.9 | 5.39 | 6 | 0.52 | 0.53 | 0.50 | Unchanged∥ | ||
P07029 | hnRNP UP2 | mRNA splicing | 24.1 | 8.02 | 1 | 1.0 | 0.68 | ND | Unchanged∥ | ||
P43331 | snRNP D3 | mRNA splicing | 13.9 | 10.3 | 2 | ND | 0.39 | 0.41 | Unchanged∥25 | ||
P08578 | snRNP E | mRNA splicing | 10.8 | 9.46 | 2 | 0.71 | 0.62 | 0.59 | Unchanged∥ | ||
Q13822 | E-NPP 2 | Glycolysis | 99.0 | 7.14 | 2 | ND | ND | 0.31 | Unknown | ||
P22712 | MBP-1 | Transcription | 37.0 | 6.79 | 2 | ND | 0.15 | ND | Unknown | ||
Q9BWX5 | GATA-5 | Transcription | 41.3 | 9.17 | 1 | 1.5 | ND | 2.6 | Unknown | ||
Q14974 | Importin β-1 | Transport | 97.2 | 4.68 | 2 | 1.5 | ND | 2.1 | Repressed24 | ||
P24903 | CYPIIF1 | Cellular defense | 55.5 | 6.93 | 2 | 1.6 | ND | 1.8 | Unknown | ||
P52565 | Rho GDI 1 | Signal transduction | 23.2 | 5.03 | 2 | 2.3 | 1.7 | ND | Unknown | ||
P31146 | Coronin 1A | Signal transduction | 51.0 | 6.25 | 3 | 2.2 | ND | ND | Unknown | ||
NP_000994 | 60S P1 protein | Protein synthesis | 11.5 | 4.26 | 2 | 1.0 | 1.5 | 1.8 | Unknown | ||
P15531 | NDP kinase A | Energy | 17.1 | 5.83 | 2 | 0.9 | 1.5 | ND | Unknown | ||
P05109 | Calgranulin A | Cellular defense | 10.8 | 6.51 | 2 | ND | 2.0 | 2.1 | Induced23 | ||
Q99733 | NAP2 | Not defined | 42.7 | 4.60 | 3 | 1.2 | ND | 1.9 | Unknown | ||
P47755 | CapZ α-2 | Structural | 32.9 | 5.57 | 2 | 1.8 | 2.2 | 2.6 | Unknown | ||
P12814 | α-actinin 1 | Structural | 103 | 5.22 | 3 | 2.7 | 2.3 | 2.8 | Unknown | ||
Q08043 | α-actinin 3 | Structural | 103 | 5.40 | 3 | 3.4 | ND | ND | Unknown | ||
P35579 | NMMHC-A | Structural | 226 | 5.50 | 3 | 2.0 | 4.1 | 4.3 | Unknown | ||
P29590 | isoform PML-1 | Negative regulator | 97.5 | 5.88 | 2 | 3.5 | ND | ND | Unknown |
eEF indicates eukaryotic translation elongation factor; c-H-ras, transforming protein p21/H-Ras-1; c-mos, proto-oncogene serine/threonine-protein kinase mos; PP2A, serine/threonine protein phosphatase 2A; MEKK 1, mitogen-activated protein kinase kinase kinase 1; MPO, myeloperoxidase; CDC42 homolog, G25K guanosine triphosphate (GTP)-binding protein; SAR1a, GTP-binding protein SAR1a; hnRNP, heterogeneous nuclear ribonucleoprotein; snRNP, small nuclear ribonucleoprotein; E-NPP 2, ectonucleotide pyrophosphatase/phosphodiesterase 2; MBP-1, C-myc promoter-binding protein; GATA-5, transcription factor GATA-5; CYPIIF1, cytochrome P450 2F1; NDP kinase A, nucleoside diphosphate kinase A; NAP2, nucleosome assembly protein 1—like 4; actinin, F-actin cross-linking protein; NMMHC-A, myosin heavy chain, nonmuscle type A; isoform PML-1, probable transcription factor PML. For other abbreviations, see Table 1.
Theoretical.
ATRA-treated divided by nontreated. All values are statistically significant, P < .05.
The mRNA expression is as displayed in references Liu et al23 (for 0 to 72 hours), Yang et al24 (for 0 to 96 hours), or Lee et al25 (for 0 to 48 hours) or by personal communication. Unchanged mRNA expression ratios (for ATRA treated divided by nontreated) were within 0.8 to 1.2 as a function of various ATRA treatment time points.
See Figure 4.
Also in Table 1.